首页> 外国专利> ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ATORVASTATIN AND EZETIMIBE

ORAL TABLET FORMULATION CONSISTING OF FIXED COMBINATION OF ATORVASTATIN AND EZETIMIBE

机译:阿托伐他汀与依泽替尼固定组合的口服片剂配方

摘要

The present invention is an orally consumed fixed combination formulation of both atorvastatin and ezetimibe in one tablet that is expected to have same Area Under Curve as two active ingredients taken together individually orally, and pharmaceutically acceptable additives suitable for the preparation. In preferred embodiments of this invention, the atorvastatin is in the form of atorvastatin calcium and the pharmaceutically acceptable additives are selected from the diluents, disintegrants, glidants, lubricants, colorants and combinations thereof.
机译:本发明是一种阿托伐他汀和依泽替米贝在口服片剂中的口服消耗的固定组合制剂,其预期具有与两种单独口服的两种活性成分相同的曲线下面积,以及适合于该制剂的药学上可接受的添加剂。在本发明的优选实施方案中,阿托伐他汀为阿托伐他汀钙的形式,并且药学可接受的添加剂选自稀释剂,崩解剂,助流剂,润滑剂,着色剂及其组合。

著录项

  • 公开/公告号WO2013166114A1

    专利类型

  • 公开/公告日2013-11-07

    原文格式PDF

  • 申请/专利权人 ALTHERA LIFE SCIENCES LLC;

    申请/专利号WO2013US39012

  • 发明设计人 DIAS MARIE CHARMAINE;

    申请日2013-05-01

  • 分类号A61K9/24;

  • 国家 WO

  • 入库时间 2022-08-21 16:29:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号